This article analyzes the hydrogen peroxide deactivation kinetics of representative bioburden in the pharmaceutical, healthcare and food industries, as well as the role of microbial and process variables, such as, type of microorganism (Geobacillus stearothermophilus or Bacillus atrophaeus), temperature, or particle distribution impact over the deactivation process. In addition, the effect of the use of an atomized hydrogen peroxide technology for surface decontamination against the two spore formers microorganisms is also explored.

By Ignacio Cantera, PhD, R&D Pharma Manager at Telstar

Full link:

https://www.telstar.com/wp-content/uploads/2022/10/Telstar-White-Paper-Deactivation-capabilities-HP-set22.pdf

Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream